Clinical Trial Update: Safety Comparison of Pioglitazone and Glyburide in Type 2 Diabetes Subjects With Mild to Moderate Congestive Heart Failure [Phase 3]

View source ↗

Summary

Phase 3 safety comparison trial comparing pioglitazone and glyburide in adults with type 2 diabetes mellitus and mild to moderate congestive heart failure; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure
• Type 2 Diabetes Mellitus

Drugs mentioned

• Actos (Pioglitazone)
• Glyburide (glyburide)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: TERMINATED